Company profile

Telormedix SA

Telormedix is a clinical stage biopharmaceutical company focused on targeted immunity in the treatment of cancer and other diseases.

More news about Telormedix SA

08.12.2014 12:34

Orphan Drug Status Granted to Telormedix´ lead product

Please login or
register to use the
awards follow feature
19.05.2014 09:05

Telormedix’s Cancer Drug Successfully Completes Phase II Trials

Please login or
register to use the
awards follow feature
02.12.2013 09:13

Telormedix Raises CHF 6 M in Series B Financing Round

Please login or
register to use the
awards follow feature
07.08.2013 09:27

Telormedix Receives EU Funding

Please login or
register to use the
awards follow feature
07.01.2013 09:42

Telormedix: Go-ahead for Phase II trials

Please login or
register to use the
awards follow feature
06.03.2012 12:31

Telormedix and SUPSI Receive Funding from CTI

Please login or
register to use the
awards follow feature
25.01.2012 09:27

Telormedix Secures Further Funding

Please login or
register to use the
awards follow feature
Telormedix SA

Founded
2007

Kanton
TI

Homepage

rss